Clinical Study
Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
Table 3
Relative risks of returning to wellness program for patients with CD4 > 250 on the day of testing HIV-positive.
| Variable | Adjusted relative risks (95% CI) | P value |
| Pilot Period | 1.02 (0.69–1.50) | 0.92 | Baseline period | Reference | | Employed | 1.95 (1.32–2.87) | 0.00 | Unemployed | Reference | | Female | 1.16 (0.77–1.75) | 0.47 | Male | Reference | | Age 18–29 | 0.50 (0.28–0.91) | 0.02 | Age 30–39 | |
*
| Age 40–49 | 0.71 (0.42–1.19) | 0.19 | Age 50+ | 1.27 (0.77–2.09) | 0.34 | CD4 350 on day of HIV testing | Reference |
*
| CD4 > 350 on day of HIV testing | 0.68 (0.47–1.00) | 0.05 |
|
|
Relative risks estimated using modified Poisson approach.
|